
The Embrex Inovoject® Egg Injection System: The worldwide standard for in ovo delivery
The Embrex Inovoject System is Pfizer Poultry Health Division’s patented platform technology, enabling the delivery of biologicals and pharmaceuticals to chick embryos. It is a controlled, sanitary, less labor-intensive system that delivers nearly 100 percent inoculation rates; it makes possible an early stimulation of the immune system, and minimizes stress to the bird. Studies show these combined benefits typically result in healthier birds for producers. The Inovoject system has become the industry leader because it works. With more than 42 models available, the Inovoject system can accommodate most egg flat and hatching basket configurations.
Market Acceptance
Over 600 Embrex Inovoject Systems are operating worldwide in more than 30 countries injecting over 10 billion eggs per year. More than 70 billion eggs have been injected since the Inovoject system was introduced in 1992.
Proven Benefits
A Solid Future
PPHD is the global leader in developing and marketing in ovo delivery systems for the poultry industry. The company's proprietary Inovoject egg injection system can inoculate and transfer up to 70,000 eggs per hour, eliminating the need for traditional manual post-hatch injection of chicks. PPHD is developing and implementing system advancements regularly to help increase the productivity and profitability of customers worldwide.